Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3-to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial - Saver, JL; Gornbein, J; Grotta, J (Stroke, 2009)
et al.